Thermo Fisher Scientific Debuts Pharmacogenetic Test to Improve Transplant Safety
Proper dosing helps prevent potential side effects such as developing diabetes and kidney damage
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
GRAIL’s Moves with MCED Test Illustrate Direct-to-Consumer Surge
By partnering with Hims & Hers and Epic, GRAIL bypasses traditional lab test arrangement
GNPC identifies subset of proteins elevated across Alzheimer’s and Parkinson’s
Consortium hosts large proteomics dataset for neurodegenerative diseases
New Guidelines, High-Cost Treatments Driving Surge in HCV Testing
...
Already a member? Log in here
Drug Monitoring Can Impact Utilization In Patients on Opioid Therapy
...
Already a member? Log in here
Value of Multigene Panels Emerging
...
Already a member? Log in here
G2 Insider: Patients Place Too Much Confidence in Prognostic Gene Profiles
...
Already a member? Log in here
miRNA in Semen a Better ID of Prostate Cancer Than PSA
...
Already a member? Log in here
Molecular Diagnostic to Make Laser Eye Surgery Safer
...
Already a member? Log in here
Study Urges No Routine Histological Exam in Orthopedic Surgeries
...
Already a member? Log in here
Technology Evolving Slowly in U.S. Pertussis Testing
...
Already a member? Log in here
MALDI-TOF Generates Substantial Cost Savings
...
Already a member? Log in here